Sekisui Diagnostics LLC  

Burlington,  MA 
United States
http://www.sekisuidiagnostics.com
  • Booth: 2523

Booth Profile

Headquartered in Burlington, MA, for over 30 years Sekisui Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. Sekisui Diagnostic’s workforce includes over 500 employees, in six sites located in four countries. We are a sister company to Sekisui Medical in Japan and in China, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry systems and reagents • Coagulation systems and reagents • Rapid tests, immunoassay and molecular point of care test systems • Enzymes and specialty biochemicals


 Products

  • FastPack® IP Sex Hormone Binding Globulin (SHBG)
    FastPack® IP SHBG is a chemiluminescent immunoassay intended for the quantitative determination of Sex Hormone Binding Globulin in human serum and plasma on the FastPack® System. The FastPack® IP SHBG assay is intended for use as an aid in the diagnosis of androgen disorders. • Quantitative Measurement of total testosterone • Results in 8 minutes...

  • FastPack® IP SHBG is a chemiluminescent immunoassay intended for the quantitative determination of Sex Hormone Binding Globulin in human serum and plasma on the FastPack® System. The FastPack® IP SHBG assay is intended for use as an aid in the diagnosis of androgen disorders.

    Measurement of SHBG in addition to total testosterone enables the calculation of free and bio-available testosterone. Physicians can better interpret their patients’ androgen status with a comprehensive understanding of the differences between total, free, and bio-available testosterone. This is particularly important when total testosterone levels are not consistent with clinical symptoms.

    The FastPack® IP system enables physicians to diagnose androgen disorders, monitor testosterone therapy, and make adjustments in a single patient visit.